🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In a new Mayo Clinic study, a semi-automatic system called RENEW (REanalysis of NEgative Whole-exome/genome data) provided probable diagnoses for 63 out of 1,066 previously undiagnosed patients. mayocl.in/3YghGw5

When you get an opportunity to write #CMML diagnostic criteria for the World Health Organization (WHO) with the dream team. Eric Padron MD Raphael Itzykson Joseph D. Khoury, MD, FCAP #Ericsolary Mayo Clinic Comprehensive Cancer Center Moffitt Cancer Center

Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired bone marrow failure syndromes ... sciencedirect.com/science/articl… yael kusne MD PhD Tim Chlon Talha Badar Mayo Clinic Comprehensive Cancer Center #DDX41 #Bonemarrowfailure

Nice work by Abhishek Mangaonkar on lack of impact of lymphoid aggregates in patients with #MDS. Should not prevent from enrolling in trials. Mayo Clinic Comprehensive Cancer Center #MDSsm British Journal of Haematology British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…

September is #PulmonaryFibrosis Awareness Month! Join us for 'Pulmonary Fibrosis Fridays' as we raise awareness about #PF, its symptoms, diagnosis, and treatment. Refer to our Diagnosis and Management Guidelines for more information about PF in TBDs: bit.ly/TBD_Guidelines

newsnetwork.mayoclinic.org/discussion/may… Thank you Team Telomere Mayo Clinic Center for Individualized Medicine Alex Ferrer Abhishek Mangaonkar Terra Lasho, PhD @KB_McCullough Doug Simonetto, MD Eva Carmona and numerous others Mayo Clinic Comprehensive Cancer Center

Welcome to Telomere Biology Disorder Awareness Month! This year, we are celebrating 15 years since Team Telomere’s 501c3 status. Join us for #TeamTelomere15! With your help, we can keep building brighter tomorrows for the TBD community. #TelomereBiologyDisorders #TBD

Really glad I got to participate in this stimulating discussion on the clinical implication of #ClonalHematopoiesis in #Telomere disorders with Daria Babushok Lab Alex Ferrer and Chris Reilly - hopefully continued discussion will lead to utilization of these data in clinical care.

Great job by Terra Lasho, PhD presenting the bone phenotype observed in the #MayoClinic #TBD cohort at ASH 2024 workshop. Mrinal Patnaik Abhishek Mangaonkar

Never too late to congratulate Jenna Fernandez and Mrinal Patnaik for the brilliant abstract on #VEXAS presented yesterday at the poster session! it’s been amazing to collaborate with this team on #VEXAS studies! Emma M. Groarke Bhavisha Patel #ASH24 ASH

Here's a look at 10 pioneering studies from Mayo Clinic’s Center for Individualized Medicine in 2024: mayocl.in/4gtZsgL

Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response ashpublications.org/bloodadvances/… Why does #DNMT3A #CH increase mortality in the context of #COVID19 and #VEXAS #multiomics Mayo Clinic Comprehensive Cancer Center MaiaLab

Today MayoPCCM grand rounds, #DrEvaCarmona talking to us about Advancements and Genetic testing for #fibroticILD #MedEd #MedTwitter Alex Ferrer

Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome - spectrum of #CH and #Cytopenias in 195 patients with #DDX41MTGPS ⁦yael kusne MD PhD⁩ ⁦⁦Talha Badar⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ pubmed.ncbi.nlm.nih.gov/40040251/

Watch our interview with Mrinal Patnaik (Mayo Clinic) from #IBC2025 to learn about the difference between age-related clonal hematopoiesis and context-relevant CH. Click here for the interview: 👉 ow.ly/BsSX50VkCIi 👈 #HemOnc #Leusm #AMLsm

Download your FREE copy of the TBD Diagnosis and Management Guidelines teamtelomere.org/diagnosis-mana…, a cornerstone resource with input from 60 clinicians/researchers that provides critical information to our community #TeamTelomere #TelomereBiologyDisorder #RareDisease

Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific membrane antigen therapy pubmed.ncbi.nlm.nih.gov/40176753/ #Lutetium #CH #PPM1D #TP53 #prostate yael kusne MD PhD Mayo Clinic Comprehensive Cancer Center

¡Nuestros folletos informativos ya están disponibles en español! Obtenga acceso a la biblioteca completa de folletos en: teamtelomere.org/one-pager-reso… -- Our One-Pager Resources are Now Available in Spanish! To access and download visit our website: teamtelomere.org/one-pager-reso…

Join us for Cocktails & Chromosomes - New York City on August 5th at Hogan Lovells! Celebrate our community with an elegant evening of meaningful moments. Tickets are open! Secure your spot + view sponsorships:teamtelomere.org/cocktails-chro…

Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. pubmed.ncbi.nlm.nih.gov/40040251/ #CH #CCUS #R525H